Trying to learn how to translate from the human translation examples.
From professional translators, enterprises, web pages and freely available translation repositories.
ranolasiini toime muudele ravimitele
effects of ranolazine on other medicinal products
Last Update: 2017-04-26
Usage Frequency: 5
Quality:
Üks tablett sisaldab 375 mg ranolasiini.
each tablet contains 375 mg of ranolazine.
Last Update: 2017-04-26
Usage Frequency: 9
Quality:
ranolasiini toimemehhanism on suures osas teadmata.
the mechanism of action of ranolazine is largely unknown.
Last Update: 2012-04-11
Usage Frequency: 2
Quality:
dialüüsi mõju ranolasiini farmakokineetikale ei ole hinnatud.
the influence of dialysis on the pharmacokinetics of ranolazine has not been evaluated.
Last Update: 2017-04-26
Usage Frequency: 2
Quality:
cyp3a4 inhibiitorid suurendavad ranolasiini kontsentratsiooni vereplasmas.
inhibitors of cyp3a4 increase plasma concentrations of ranolazine.
Last Update: 2017-04-26
Usage Frequency: 3
Quality:
ranexa on ravim, mis sisaldab toimeainena ranolasiini.
ranexa is a medicine that contains the active substance ranolazine.
Last Update: 2017-04-26
Usage Frequency: 3
Quality:
toit ei mõjuta ranolasiini imendumise määra ega ulatust.
food does not affect the rate and extent of absorption of ranolazine.
Last Update: 2017-04-26
Usage Frequency: 3
Quality:
ranolasiini kasutamise kohta rasedatel ei ole piisavalt andmeid.
there are no adequate data from the use of ranolazine in pregnant women.
Last Update: 2012-04-11
Usage Frequency: 2
Quality:
Üks toimeainet prolongeeritult vabastav tablett sisaldab 375 mg ranolasiini.
each prolonged-release tablet contains 375 mg ranolazine.
Last Update: 2017-04-26
Usage Frequency: 9
Quality:
põhilises annuse kindlaksmääramise uuringus marisa kasutati ranolasiini monoteraapiana.
in the main dose-finding study, marisa, ranolazine was used as monotherapy.
Last Update: 2017-04-26
Usage Frequency: 5
Quality:
kõikide ranolasiini toimeainet prolongeeritult vabastavate tablettide abiained: karnaubavaha
excipients for all ranolazine prolonged-release tablets: carnauba wax
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
rasedus: ranolasiini kasutamise kohta rasedatel ei ole piisavalt andmeid.
pregnancy: there are no adequate data from the use of ranolazine in pregnant women.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
maksakahjustus: ranolasiini farmakokineetikat on uuritud kerge või mõõduka maksakahjustusega patsientidel.
hepatic impairment: the pharmacokinetics of ranolazine have been evaluated in patients with mild or moderate hepatic impairment.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
ranolasiini farmakokineetilisi parameetreid pediaatrilisel populatsioonil (< 18 aastat) ei ole uuritud.
the pharmacokinetic parameters of ranolazine have not been studied in the paediatric population (< 18 years).
Last Update: 2012-04-11
Usage Frequency: 2
Quality:
Warning: Contains invisible HTML formatting
rifampitsiin (600 mg üks kord päevas) vähendab ranolasiini tasakaalukontsentratsioone ligikaudu 95%.
rifampicin (600 mg once daily) decreases ranolazine steady-state concentrations by approximately 95%.
Last Update: 2012-04-11
Usage Frequency: 2
Quality:
ranexa toimeainet ranolasiini arvatakse toimivat sel viisil, et see vähendab naatriumiioonide sisenemist südamelihase rakkudesse.
the active substance in ranexa, ranolazine, is thought to work by reducing the flow of sodium ions into the heart muscle cells.
Last Update: 2017-04-26
Usage Frequency: 3
Quality:
ranolasiini lõplik poolväärtusaeg püsikontsentratsioonil pärast suukaudset manustamist on ligikaudu 7 tundi, kuna eliminatsiooni piirab imendumismäär.
the terminal half-life at steady state after oral administration of ranolazine is about 7 hours, due to the absorption rate-limited elimination.
Last Update: 2017-04-26
Usage Frequency: 3
Quality:
verapamiil (120 mg kolm korda päevas) suurendab ranolasiini tasakaalukontsentratsioone 2,2-kordselt.
verapamil (120 mg three times daily) increases ranolazine steady-state concentrations 2.2-fold.
Last Update: 2017-04-26
Usage Frequency: 3
Quality:
võttes arvesse kõiki teatatud juhte, on olemas tugev põhjuslik seos ranolasiini kasutamise ja raskekujulise hüponatreemia esinemise vahel.
considering all reported cases, there is a strong causality relation between the use of ranolazine and the occurrence of severe hyponatremia.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
cyp2d6 inhibiitorid: ranolasiini metaboliseerib osaliselt cyp2d6; seetõttu võivad selle ensüümi inhibiitorid suurendada ranolasiini kontsentratsioone vereplasmas.
cyp2d6 inhibitors: ranolazine is partially metabolised by cyp2d6; therefore, inhibitors of this enzyme may increase plasma concentrations of ranolazine.
Last Update: 2017-04-26
Usage Frequency: 1
Quality: